SUNESIS PHARMACEUTICALS Aktie

1,28 EUR 3,9740%

Zu Ihrem Onlinebroker

kaufen verkaufen

SUNESIS PHARMACEUTICALS Aktienkurs : 13.02. ( 15 Min. verzögert)
1,28 € Letzter Kurs	3,97% Veränderung	1,23 € Vortag	1,28 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
1,28 - 1,23 Tag	2,09 - 0,801 52 Wochen	0 Tag	95 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

SUNESIS PHARMACEUTICALS Aktie…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

07.02.

Sunesis to Present at the 14th Annual BIO CEO & Investor Conference

7, 2012 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at the 14 th Annual...
07.02.

Sunesis to Present at the 14th Annual BIO CEO & Investor Conference

SOUTH SAN FRANCISCO, Calif., Feb 7, 2012 (GlobeNewswire via COMTEX) -- Sunesis Pharmaceuticals, Inc. /quotes/zigman/3993163/quotes/nls/snss SNSS +2.63% today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at the ...

02.02.

Sunesis Announces Appointment of Dr. Adam R. Craig as Chief Medical Officer

2, 2012 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. /quotes/zigman/3993163/quotes/nls/snss SNSS +1.05% today announced the appointment of Adam R. Craig, MBBS, Ph.D., MBA to the newly created position...
27.01.

Amgen Buys Micromet For Its Leukemia Drugs: A Look a Two Other Biotech Stocks ...

A closer look at biotech stocks CytRx Corporation (CYTR) and Sunesis Pharmaceuticals (SNSS) with leukemia treatments after Amgen (AMGN) announced they will buy biotech Micromet (MITI). By John Udovich Amgen (NASDAQ: AMGN)...
26.01.

Small Biotechnology Stocks Roar, Profit Now

While these have already made a move, charts of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) and ADVENTRX Pharmaceuticals, Inc. (NYSEAMEX:ANX) both look attractive. ADVENTRX is trading at one-half cash value. Disclosure: Chief Market...